{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:16:30Z","timestamp":1790486190790,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1124\/mol.118.114827","type":"journal-article","created":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T00:25:38Z","timestamp":1559953538000},"page":"158-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Severe Hepatotoxicity of Mithramycin Therapy Caused by Altered Expression of Hepatocellular Bile Transporters"],"prefix":"10.1016","volume":"96","author":[{"given":"Tristan M.","family":"Sissung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phoebe A.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph J.","family":"Hauke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edel M.","family":"McCrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody J.","family":"Peer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto H.","family":"Barbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Strope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel M.","family":"Ley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Venzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Grohar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Glod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte C.","family":"Widemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Schrump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Figg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.118.114827_bib1","doi-asserted-by":"crossref","first-page":"54028","DOI":"10.18632\/oncotarget.9927","article-title":"DMET\u2122 (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine","volume":"7","author":"Arbitrio","year":"2016","journal-title":"Oncotarget"},{"key":"10.1124\/mol.118.114827_bib2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/bjc.1968.25","article-title":"A clinical trial of mithramycin in the treatment of advanced malignant disease","volume":"22","author":"Baum","year":"1968","journal-title":"Br J Cancer"},{"key":"10.1124\/mol.118.114827_bib3","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1172\/JCI115474","article-title":"Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo","volume":"88","author":"Blume","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.118.114827_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-2002-30099","article-title":"Mechanisms of hepatic transport of drugs: implications for cholestatic drug reactions","volume":"22","author":"Bohan","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1124\/mol.118.114827_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2217\/clp.12.12","article-title":"Hepatobiliary transport in health and disease","volume":"7","author":"Chan","year":"2012","journal-title":"Clin Lipidol"},{"key":"10.1124\/mol.118.114827_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3727\/105221618X15156018385515","article-title":"Bile acid metabolism in liver pathobiology","volume":"18","author":"Chiang","year":"2018","journal-title":"Gene Expr"},{"key":"10.1124\/mol.118.114827_bib7","doi-asserted-by":"crossref","first-page":"G979","DOI":"10.1152\/ajpgi.00370.2011","article-title":"Bile acids via FXR initiate the expression of major transporters involved in the enterohepatic circulation of bile acids in newborn mice","volume":"302","author":"Cui","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/mol.118.114827_bib8","first-page":"18","article-title":"Mithramycin-human toxicology and preliminary therapeutic investigation","volume":"8","author":"Curreri","year":"1960","journal-title":"Cancer Chemother Rep"},{"key":"10.1124\/mol.118.114827_bib9","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1194\/jlr.R900012-JLR200","article-title":"Bile acid transporters","volume":"50","author":"Dawson","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1124\/mol.118.114827_bib10","first-page":"1379","article-title":"Hepatic toxicity of low doses of mithramycin in hypercalcemia","volume":"68","author":"Green","year":"1984","journal-title":"Cancer Treat Rep"},{"key":"10.1124\/mol.118.114827_bib11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00280-017-3382-x","article-title":"A phase I\/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS-FLI1 fusion transcript","volume":"80","author":"Grohar","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1124\/mol.118.114827_bib12","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/jnci\/djr156","article-title":"Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening","volume":"103","author":"Grohar","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/mol.118.114827_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2012.08.002","article-title":"Bile acid transporters and regulatory nuclear receptors in the liver and beyond","volume":"58","author":"Halilbasic","year":"2013","journal-title":"J Hepatol"},{"key":"10.1124\/mol.118.114827_bib14","doi-asserted-by":"crossref","first-page":"51085","DOI":"10.1074\/jbc.M308321200","article-title":"Farnesoid X receptor activates transcription of the phospholipid pump MDR3","volume":"278","author":"Huang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.118.114827_bib15","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1089\/aivt.2016.0023","article-title":"Basolateral efflux transporters: a potentially important pathway for the prevention of cholestatic hepatotoxicity","volume":"2","author":"Jackson","year":"2016","journal-title":"Appl In Vitro Toxicol"},{"key":"10.1124\/mol.118.114827_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/aivt.2018.0011","article-title":"Cholestatic drug induced liver injury: a function of bile salt export pump inhibition and farnesoid X receptor antagonism","volume":"4","author":"Jackson","year":"2018","journal-title":"Appl In Vitro Toxicol"},{"key":"10.1124\/mol.118.114827_bib17","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.bbrc.2012.12.041","article-title":"Functional characterization of genetic variations in the MDR3 promoter","volume":"430","author":"Jang","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/mol.118.114827_bib18","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/1097-0142(197010)26:4<755::AID-CNCR2820260403>3.0.CO;2-U","article-title":"Mithramycin therapy in advanced testicular neoplasms","volume":"26","author":"Kennedy","year":"1970","journal-title":"Cancer"},{"key":"10.1124\/mol.118.114827_bib19","first-page":"77","article-title":"Mithramycin in the treatment of disseminated cancer","volume":"32","author":"Kofman","year":"1963","journal-title":"Cancer Chemother Rep"},{"key":"10.1124\/mol.118.114827_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.fpc.0000230418.28091.76","article-title":"Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury","volume":"17","author":"Lang","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/mol.118.114827_bib21","article-title":"Mithramycin inhibits epithelial-to-mesenchymal transition and invasion by downregulating SP1 and SNAI1 in salivary adenoid cystic carcinoma","volume":"39","author":"Li","year":"2017","journal-title":"Tumour Biol"},{"key":"10.1124\/mol.118.114827_bib22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.aanat.2010.07.010","article-title":"The role of Sp1 and Sp3 in normal and cancer cell biology","volume":"192","author":"Li","year":"2010","journal-title":"Ann Anat"},{"key":"10.1124\/mol.118.114827_bib23","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.2147\/IJN.S139507","article-title":"Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma","volume":"12","author":"Liu","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"10.1124\/mol.118.114827_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00253-006-0511-6","article-title":"The aureolic acid family of antitumor compounds: structure, mode of action, biosynthesis, and novel derivatives","volume":"73","author":"Lomb\u00f3","year":"2006","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1124\/mol.118.114827_bib25","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"10.1124\/mol.118.114827_bib26","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/mp0700357","article-title":"Use of sandwich-cultured hepatocytes to evaluate impaired bile acid transport as a mechanism of drug-induced hepatotoxicity","volume":"4","author":"Marion","year":"2007","journal-title":"Mol Pharm"},{"key":"10.1124\/mol.118.114827_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1517\/17460441.2014.860129","article-title":"Characterizing ligands for farnesoid X receptor--available in vitro test systems for farnesoid X receptor modulator development","volume":"9","author":"Merk","year":"2014","journal-title":"Expert Opin Drug Discov"},{"key":"10.1124\/mol.118.114827_bib28","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.2217\/pgs.15.68","article-title":"Predicting paclitaxel-induced neutropenia using the DMET platform","volume":"16","author":"Nieuweboer","year":"2015","journal-title":"Pharmacogenomics"},{"key":"10.1124\/mol.118.114827_bib29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1053\/jhep.2002.31724","article-title":"Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump","volume":"35","author":"Plass","year":"2002","journal-title":"Hepatology"},{"key":"10.1124\/mol.118.114827_bib30","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1021\/acs.molpharmaceut.5b00659","article-title":"Disruption of BSEP function in HepaRG cells alters bile acid disposition and is a susceptive factor to drug-induced cholestatic injury","volume":"13","author":"Qiu","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1124\/mol.118.114827_bib31","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1158\/1078-0432.CCR-14-3379","article-title":"Mithramycin depletes specificity protein 1 and activates p53 to mediate senescence and apoptosis of malignant pleural mesothelioma cells","volume":"22","author":"Rao","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.118.114827_bib32","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jama.1968.03140250010003","article-title":"Mithramycin therapy in disseminated germinal testicular cancer","volume":"204","author":"Ream","year":"1968","journal-title":"JAMA"},{"key":"10.1124\/mol.118.114827_bib33","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/hep.23937","article-title":"Drug-induced acute liver failure: results of a U.S. multicenter, prospective study","volume":"52","author":"Reuben","year":"2010","journal-title":"Hepatology"},{"key":"10.1124\/mol.118.114827_bib34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jchromb.2014.08.021","article-title":"Quantitative determination of mithramycin in human plasma by a novel, sensitive ultra-HPLC-MS\/MS method for clinical pharmacokinetic application","volume":"970","author":"Roth","year":"2014","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1124\/mol.118.114827_bib35","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1517\/14728222.2014.914173","article-title":"Transcription factor Sp1, also known as specificity protein 1 as a therapeutic target","volume":"18","author":"Safe","year":"2014","journal-title":"Expert Opin Ther Targets"},{"key":"10.1124\/mol.118.114827_bib36","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.2174\/092986712801661077","article-title":"Expression of specificity protein transcription factors in pancreatic cancer and their association in prognosis and therapy","volume":"19","author":"Sankpal","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1124\/mol.118.114827_bib37","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/bjc.1966.32","article-title":"A trial of mithramycin in the treatment of advanced malignant disease","volume":"20","author":"Sewell","year":"1966","journal-title":"Br J Cancer"},{"key":"10.1124\/mol.118.114827_bib38","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.celrep.2016.12.064","article-title":"Oncogenes activate an autonomous transcriptional regulatory circuit that drives glioblastoma","volume":"18","author":"Singh","year":"2017","journal-title":"Cell Rep"},{"key":"10.1124\/mol.118.114827_bib39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jceh.2013.10.005","article-title":"Progressive familial intrahepatic cholestasis","volume":"4","author":"Srivastava","year":"2014","journal-title":"J Clin Exp Hepatol"},{"key":"10.1124\/mol.118.114827_bib40","first-page":"36","article-title":"Mithramycin inhibition of ribonucleic acid synthesis","volume":"26","author":"Yarbro","year":"1966","journal-title":"Cancer Res"},{"key":"10.1124\/mol.118.114827_bib41","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1158\/0008-5472.CAN-11-3983","article-title":"Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells","volume":"72","author":"Zhang","year":"2012","journal-title":"Cancer Res"},{"issue":"4","key":"10.1124\/mol.118.114827_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.329","article-title":"Obeticholic acid, a selective farnesoid X receptor agonist, regulates bile acid homeostasis in sandwich-cultured human hepatocytes","volume":"5","author":"Zhang","year":"2017","journal-title":"Pharmacol Res Perspect"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24008812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24008812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.118.114827","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:28:29Z","timestamp":1739960909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24008812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0026895X24008812"],"URL":"https:\/\/doi.org\/10.1124\/mol.118.114827","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe Hepatotoxicity of Mithramycin Therapy Caused by Altered Expression of Hepatocellular Bile Transporters","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.118.114827","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}